DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Zhu AX, Finn RS, Ikeda M. et al.
A phase Ib study of lenvatinib (LEN) plus pembrolizumab (PEMBRO) in unresectable hepatocellular carcinoma (uHCC).
J Clin Oncol 2020;
38: 4519-4519
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.